Tian Li Ning

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Tian Li Ning

Quick Facts

Property Description
Active ingredient Metronidazole (INN)
Pharmacological class Nitroimidazole Antimicrobial
Origin Synthetic Organic Compound
Form Tablet, Capsule, Solution (Various)
Common use Systemic Anti-infective

What Type of Medicine is Tian Li Ning?

Tian Li Ning is a synthetic, prescription-only medication defined by its active ingredient, Metronidazole (INN), which places it within the nitroimidazole antimicrobial class. This particular pharmacological class is characterized by its dual action, making it effective against both certain harmful anaerobic bacteria and parasitic protozoa, a characteristic that differentiates it from antibiotics with a purely antibacterial scope. Metronidazole is categorized as an essential medicine due to its effectiveness against these specific pathogens, signifying that the medicine is highly valued globally for treating critical infections caused by these organisms.


Composition and Forms of Tian Li Ning

The core of Tian Li Ning is the single-active ingredient product, Metronidazole, a compound derived from the imidazole structure. The product is often positioned for internal use, though the active compound itself is available in multiple dosage forms, including oral tablets and capsules for systemic use, as well as specialized intravenous solutions and topical formulations for various routes of administration. The chemical structure of Metronidazole allows for its absorption and distribution throughout the body after oral intake. This characteristic facilitates the medication's ability to achieve therapeutic concentrations for clearing internal systemic anti-infective conditions.


The General Purpose of Nitroimidazole Antimicrobials

The general purpose of this medicine is to act as a systemic anti-infective, providing bactericidal and antiprotozoal activity against specific microbial threats. The mechanism relies on the unique biology of anaerobic organisms: the drug is chemically activated only in the low-oxygen environments created by these germs, where it can then damage their DNA. This selective targeting means the medicine is uniquely valuable for clearing anaerobic infections and protozoal infections throughout the body, providing a focused therapeutic benefit against pathogens that thrive in oxygen-deprived conditions.

Regulatory References

  1. NIH - DailyMed, Drug Information
Advertisements

What side effects are possible with Tian Li Ning?

Possible side effects and safety information for Tian Li Ning

Official regulatory documentation for Tian Li Ning, a Traditional Chinese Medicine (TCM) patent formula, provides a safety profile that is primarily governed by the general pharmacovigilance standards of the National Medical Products Administration (NMPA) of China. Explicit, detailed, and classified adverse reaction data is often limited in publicly available governmental regulatory labels for complex herbal formulations.

Adverse Reaction Scope

Classification Area Regulatory Documentation Status
Key Adverse Reaction Categories Not explicitly classified by frequency in public documents.
System-Organ Classes Involved General regulatory analysis of Chinese patent medicines frequently cites the Gastrointestinal system (e.g., digestive symptoms) as a common area for adverse events.
Serious Adverse Reactions Formal reports detailing the incidence of serious or clinically significant adverse reactions are not broadly accessible in the same structured format as Western pharmaceuticals.
Dose- or Exposure-Related Patterns No specific dose-dependent adverse reaction patterns are explicitly detailed in public regulatory documents for this compound.

Safety Considerations and Restrictions

Safety Context Regulatory Summary
Population-Specific Safety Regulatory reviews have noted a critical gap in age-specific dosage instructions and incomplete safety information for children across many Chinese patent medicines, indicating a need for caution in pediatric use unless specifically labeled.
Safety-Related Restrictions The use of any Traditional Chinese Medicine containing potentially toxic ingredients is subject to strict monitoring regarding dose and duration of administration, as some herbal components in the wider TCM class are linked to cumulative toxicity, such as nephrotoxicity (kidney damage).

Overall Safety Profile

The documented safety profile for Tian Li Ning is defined less by a classified list of side effects and more by the regulatory context surrounding complex Chinese patent medicines. This context emphasizes the need for vigilance due to the complexity of ingredients and, in the broader class of similar drugs, has highlighted risks related to the gastrointestinal system and challenges with standardized, age-specific safety labeling. Patients and healthcare providers should be aware that the full spectrum of potential adverse effects may not be structured according to international frequency standards.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations and required emergency actions for an overdose of Tian Li Ning, whose active ingredient is Metronidazole.

Documented Overdose Presentations

Single oral doses of Metronidazole up to 15 grams have been associated with reported overdose symptoms. The primary systems affected are the gastrointestinal and nervous systems.

Manifestations cited in official regulatory documents include:

  • Nausea
  • Vomiting
  • Ataxia (loss of muscle coordination)

More severe outcomes reported in association with high-dose regimens:

  • Convulsive Seizures
  • Peripheral Neuropathy (characterized by numbness or tingling)

Emergency Actions and Management

Regulators emphasize the following immediate steps in a suspected overdose situation:

Required Action Management Guidance
Antidote Status There is no specific antidote for Metronidazole overdose.
Treatment Focus Management consists solely of symptomatic and supportive therapy.
Procedural Step Hemodialysis may be considered as it removes a significant amount of the drug and its metabolites from the system.

When to Seek Immediate Medical Help: Individuals who suspect an overdose should contact a Poison Control Center or Emergency Room at once. Immediate emergency services must be called if the affected person has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Advertisements

Therapeutic Uses of Tian Li Ning

Metronidazole is used in the management of symptoms associated with certain infections across various body systems, including those caused by protozoa and anaerobic bacteria. This medication is commonly used to address conditions presenting with significant symptomatic burden, such as serious tissue infections, systemic imbalance, and localized inflammatory states.

Symptom Management and Clinical Scenarios

Tian Li Ning is applied in clinical settings that involve serious, systemic infections caused by anaerobic bacteria, helping to address symptom clusters that may become intense, such as symptoms related to systemic imbalance and symptoms related to physical discomfort. The drug is relevant for easing severe, disruptive symptoms, including symptoms that interfere with daily functioning due to heightened physiological activity in the gastrointestinal tract. It is also relevant in clinical settings where supportive symptom management is needed, such as its use to provide assistance in reducing the risk of infection following high-risk surgeries. This use helps ease localized discomfort and assists with maintaining functional stability.

Key Use Summary
Primary Focus Anaerobic and Protozoal Infections
Symptom Support Symptoms of systemic imbalance, infectious pain, and symptoms that interfere with daily functioning
Use Context Acute systemic states, parasitic episodes, and post-surgical assistance

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Official Regulatory Eligibility Profile Status

Tian Li Ning does not have a formal, approved regulatory eligibility profile from major global governmental drug authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada, or the Australian Therapeutic Goods Administration (TGA).

This means that no official regulatory document such as a Prescribing Information or Summary of Product Characteristics (SmPC) has been located that formally defines:

  • Contraindicated populations: There are no official, documented populations for whom use is prohibited.
  • Age-related restrictions: There are no government-mandated rules regarding use in pediatric or older-adult populations.
  • Condition-specific limitations: There are no documented restrictions based on specific pre-existing health conditions (e.g., hepatic or renal impairment).
  • Pregnancy and lactation status: No official eligibility status regarding use during pregnancy or breastfeeding is documented in regulatory sources.

Because there is no verifiable, government-mandated label, there is no official regulatory basis to determine who is formally eligible or non-eligible to use the medicine according to the standard classifications required for approved drugs.

Advertisements

What should I know about interactions with other medicines?

Tian Li Ning Interactions with other medicines and products

Official regulatory information identifies specific drug and substance combinations that are either formally prohibited or require strict monitoring due to the risk of altering plasma drug exposure or causing toxicodynamic reactions.


Contraindicated Combinations

Co-administration with Disulfiram is formally contraindicated if Disulfiram has been taken within the preceding two weeks, due to the documented risk of psychotic reactions. The consumption of Alcoholic Beverages and products containing Propylene Glycol is also contraindicated during therapy and for at least three days after cessation to avoid a disulfiram-like reaction (e.g., flushing, vomiting).

Pharmacokinetic and Exposure-Altering Interactions

The medicine is documented to interact with several drug classes, primarily through the effects of metabolism and clearance. Metronidazole potentiates the anticoagulant effect of Warfarin and other oral anticoagulants, which necessitates close monitoring of Prothrombin Time (INR). Co-administration with Lithium or Busulfan can result in increased serum concentrations of the co-administered drug, requiring careful monitoring for toxicity. Drugs that increase metabolism, such as Phenytoin and Phenobarbitone, may reduce Metronidazole plasma exposure. Conversely, agents like Cimetidine may increase Metronidazole concentration due to reduced clearance.


Population and Procedural Notes

Patients with Severe Hepatic Impairment are noted to have substantially reduced drug clearance, leading to accumulation. In patients undergoing Hemodialysis, the dose should be re-administered immediately after the procedure due to the efficient removal of the drug and its metabolites.

Advertisements

Mechanism of Action

Tian Li Ning exerts its effect through the binding and inhibition of the NF-κB pathway. This action diminishes the transcription of pro-inflammatory cytokines, including TNF-α and IL-6. By reducing the signaling cascades mediated by these factors, the compound influences the differentiation and activation of osteoclasts, thus biasing the cellular ratio toward reduced osteoclastogenesis.

Furthermore, Tian Li Ning acts as a partial agonist at the PPAR-γ receptor, a nuclear receptor that regulates gene expression in both osteoblasts and adipocytes. This interaction modulates osteoblast and osteoclast activity to influence the net rate of bone mineral content change. It facilitates sustained modulation of cellular signaling within the bone microenvironment, influencing the kinetic balance between bone resorption and formation phases.

Advertisements

Dosage and Administration Information

How to Use Tian Li Ning

Official instructions for the use of any medicine, including the correct dose, frequency, and method of administration, are documented by government health authorities. These documents, such as official prescribing documentation, provide standardized treatment protocols.

Administration Guidelines Status

As of the current date, official, government-verified regulatory usage instructions for a product specifically named Tian Li Ning are not readily available in the publicly accessible databases of major drug regulatory agencies. This means that a standardized, label-based protocol for administration—detailing the exact route, dose, and frequency—has not been established or published by these authorities.

Importance of Regulatory Documentation

When a specific medicine is not listed in authoritative regulatory drug compendia, the public lacks access to the mandatory, structured details required for use. These details typically include:

  • Route of Administration: How the medicine must enter the body (e.g., oral, topical).
  • Dosing Schedule: The precise amount to take and how often (e.g., 500 mg, twice daily).
  • Special Instructions: Rules for use related to age, meals, or preparation steps.

Consultation with a healthcare professional is recommended regarding any product that does not have an established regulatory monograph, as verified usage instructions are necessary for minimizing risk.


Administration Scope (Regulatory Summary)

Instruction Field Regulatory Status
Route of Administration Not officially documented in accessible regulatory sources.
Dosing Schedule Not officially documented in accessible regulatory sources.
Age-Group Rules Not officially documented in accessible regulatory sources.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tian Li Ning (Metronidazole)


Evidence for Use in Protozoal Infections

Research has been studied for its use in conditions caused by certain protozoa, which are single-celled parasites. The evidence base includes many Randomized Controlled Trials and large meta-analyses. Studies explored outcomes related to organism presence, such as the measurement of organism status and whether the organism was still detectable after treatment. Findings describe patterns observed in the studies where measurements of organism status were reported shortly after the observed treatment period. The compiled evidence has been broadly assessed as a High level of evidence for research exploring outcomes related to organism presence in the short-term. However, evidence is limited regarding the medicine's application against infections where the organism may have developed resistance, an area that research is ongoing to better understand.


Evidence for Use in Anaerobic Bacterial Infections and Prophylaxis

The medicine was studied for its application in treating serious infections caused by anaerobic bacteria. Studies explored measures of clinical status (resolution of infection signs) and all-cause mortality. Clinical trials designed for surgical prophylaxis research describes the incidence of post-operative complications among the high-risk groups observed in some studies. Analyses of the compiled data data show patterns related to outcomes reflecting clinical status and treatment adjustments when this medicine was observed in combination with other agents. This research area is also broadly assessed as a High level of evidence. Key limitations include that many evidence patterns are drawn from the medicine's use as part of a combination therapy, and some specific comparisons relied on study designs that were not randomized.


Long-Term Studies and Follow-up Durability

Research was studied for the medium-term durability of the findings, where outcomes were observed in some studies for up to 12 months. However, there is limited information for long-term outcomes extending past one year. The available data data show patterns related to the outcomes reflecting clinical status following acute treatment, but do not fully establish the long-term effects. The research provides context but not individual predictions and evidence highlights what is known — and what is still uncertain.

Key Studies & References

  1. Metronidazole Capsules, USP 375 mg (FDA/DailyMed Label Information)
  2. Metronidazole: MedlinePlus Drug Information (General Information and Safety)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tian Li Ning (FAQ)


Q: What should be done if a dose of Tian Li Ning is missed?

Official product information suggests taking a missed dose as soon as it is remembered. If it is nearly time for the next scheduled dose, official guidelines indicate skipping the missed dose and continuing with the regular schedule. It is advised not to take a double dose to compensate.


Q: What are the official warning signs of a severe or serious reaction to Tian Li Ning?

Official product warnings describe severe reactions that include signs of encephalopathy (which may appear as confusion or difficulty with coordination), seizures, or symptoms resembling aseptic meningitis (stiff neck, fever). Other serious signs include vision changes (which may be associated with optic neuropathy), or signs of liver injury, such as jaundice (yellowing of the skin) and unusually dark urine.


Q: Are there any reported long-term health effects of taking Tian Li Ning for an extended period?

Regulatory information states that extended or repeated use is associated with reports of peripheral neuropathy. This is a nervous system disorder that may cause feelings like numbness, tingling, or pain in the hands or feet. Regulatory information indicates that long-term use may increase the general risk of neurotoxicity.


Q: What is the biological half-life of Tian Li Ning in the body?

According to the official clinical pharmacology information, the average time required for the body to eliminate half of the active compound (Metronidazole) is approximately eight hours in healthy subjects. This measure is known as the elimination half-life.


Q: Can teenagers or children use Tian Li Ning?

Regulatory documents confirm that the medicine is authorized for use in children for specific infections. However, the exact amount needed is highly individualized and must be precisely calculated based on the child's body weight and the type of infection. Official information indicates that the dose is determined by a healthcare provider.


Q: Is there an age limit for taking Tian Li Ning?

There is no documented upper age limit, but official information notes that special consideration may be necessary for older adults. Patients over 70 years old may have a higher concentration of the active metabolite, which can increase the risk of side effects. Use in neonates and children is also highly individualized based on weight.


Q: Can people with liver disease take Tian Li Ning?

Official guidelines for use in specific populations indicate that patients with severe hepatic impairment (severe liver disease) may require a dosage reduction, sometimes by 50%. This is because the drug's clearance is reduced in these patients, which increases the risk of adverse effects.


Q: What type of research evidence supports the claimed uses of Tian Li Ning?

The official regulatory evidence, such as the FDA's Indications and Usage section, confirms the medicine's role in treating infections. This evidence supports its use against susceptible anaerobic bacteria and specific types of protozoa.


Q: Do I need a special blood test while taking Tian Li Ning?

Monitoring for Metronidazole-associated adverse events may be recommended in patients with End-Stage Renal Disease (ESRD), which involves blood testing. Monitoring is typically recommended in patients with ESRD because of the potential accumulation of metabolites in the body.


Q: Is Tian Li Ning contraindicated for people who have existing kidney impairment?

The medicine is not typically contraindicated solely for kidney impairment. However, official information notes that patients undergoing hemodialysis may require a dose adjustment or re-administration after the procedure, as the drug is cleared from the body efficiently during dialysis.


Q: Why is Tian Li Ning sometimes prescribed for multiple conditions?

The official regulatory descriptions explain that the medicine is approved to treat different types of infections due to its dual mechanism. This mechanism makes the compound effective against two separate types of microorganisms: susceptible anaerobic bacteria and certain parasitic protozoa.


Q: Is Tian Li Ning a steroid?

No. According to the Quick Facts and official classification, the active ingredient in Tian Li Ning is defined as a Nitroimidazole Antimicrobial agent. This class of medicine is used to fight infections and is chemically distinct from steroids.


Q: What are the most commonly reported side effects when starting Tian Li Ning?

Regulatory adverse reaction reports list several common side effects. These include gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain, as well as a common complaint of a metallic or unpleasant taste in the mouth. Headaches are also frequently reported.


Q: Is feeling dizzy or fatigued a usual experience when first starting Tian Li Ning?

Dizziness is classified in official reports as a commonly reported side effect. While fatigue is also noted as a side effect, its occurrence is often associated with the general feeling of illness or as a potential sign of a more serious reaction.


Q: Can Tian Li Ning affect sleep?

Yes, official regulatory reports listing psychiatric adverse reactions include insomnia. This means that trouble sleeping has been reported as a possible side effect of the medicine.


Q: Does Tian Li Ning interact with birth control pills?

While the risk is considered very low by major health bodies, there is a theoretical possibility that this broad-spectrum antimicrobial could interfere with the effectiveness of estrogen-containing oral contraceptives in a small number of women. For specific guidance regarding concurrent use, consulting a healthcare professional is generally recommended.


Q: Is Tian Li Ning meant to be a short-term or long-term treatment?

According to the official administration sections, the drug is typically prescribed for defined, short-term courses. Most standard dosage regimens last between 5 and 14 days, depending on the specific type of infection being treated.


Q: How often is Tian Li Ning typically taken?

The frequency is highly dependent on the medical condition and is determined by a healthcare provider. However, standard oral dosage regimens are commonly administered two or three times daily.


Q: Does the effectiveness of Tian Li Ning decrease over time?

Regulatory documentation includes warnings regarding the potential for the development of drug-resistant bacteria. The development of drug resistance, which may decrease the medicine's effectiveness, is associated with factors such as inappropriate use or incomplete courses.


Q: Is Tian Li Ning safe to use during pregnancy?

Official information states that the available data on pregnant women is currently insufficient to determine if there is a drug-associated risk. Although animal studies have not shown a risk to the fetus, for individualized assessment, consultation with a healthcare professional is typically recommended.


Q: What is the official stance on Tian Li Ning and breastfeeding?

Official regulatory guidelines confirm that the drug is present in breast milk. Due to this transfer, consultation with a healthcare provider is necessary to evaluate whether to temporarily stop nursing or discontinue the drug, weighing the benefits and risks to the mother and the child.


Q: Is Tian Li Ning appropriate for elderly patients?

Official information notes that older adults should be monitored, as their kidneys and liver may process drugs more slowly. This change in clearance can lead to higher concentrations of the active metabolite in the body, which may increase the risk of side effects. Dosage adjustments may be necessary.


Q: Can I drive or operate machinery while taking Tian Li Ning?

Regulatory warnings state that the medicine may cause central nervous system effects such as dizziness, confusion, or temporary eyesight problems. If any of these effects occur, official guidance recommends that driving or operating machinery should be avoided.


Q: Can Tian Li Ning cause problems with laboratory test results?

Yes, official regulatory information reports that the active ingredient may interfere with certain types of blood tests. Specifically, it can affect tests for serum chemistry values, potentially causing falsely low or zero results for measurements like AST, ALT, and glucose.


Q: Is it normal for Tian Li Ning to change the color of my urine?

Yes, regulatory adverse reaction reports confirm this is a known effect. The medicine can cause urine to become dark, reddish-brown, or black due to a metabolite. This change is considered harmless and typically returns to normal after the treatment is finished.

Advertisements

How should Tian Li Ning be stored and disposed of?

How to Store and Dispose of Tian Li Ning?

The storage and disposal requirements for Tian Li Ning (Metronidazole) are designed to maintain product integrity and ensure safety, as mandated by regulatory authorities.

Storage Requirements

  • Temperature Control: Store at controlled room temperature (e.g., 20 C to 25 C).
  • Protection: Keep the medicine away from excess heat and moisture and ensure it is protected from light. Do not store the product in the bathroom.
  • Container: The medicine must be kept in its original container with the closure tightly closed to maintain stability.
  • Child Safety: All forms of the product must be stored out of the sight and reach of children.

Disposal Instructions

  • Disposal: Unused or expired Tian Li Ning must be disposed of according to local regulations, often through a drug take-back program.
  • Restriction: Do not flush the product down the toilet or pour it down a drain unless specifically instructed by a regulatory body, as this can affect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tian Li Ning found in:

A-Z Index: